DOSE: Effect of Plant Stanols on Cholesterol Absorption

Sponsor
Oy Foodfiles Ltd (Other)
Overall Status
Completed
CT.gov ID
NCT00441857
Collaborator
(none)
60
1
2
29.9

Study Details

Study Description

Brief Summary

This study aims to measure the effect of three different doses of plant stanols in margarine on the cholesterol absorption efficiency in subjects with mildly to moderately increased serum LDL cholesterol concentrations

Condition or Disease Intervention/Treatment Phase
  • Behavioral: plant stanol consumption
Phase 4

Detailed Description

Serum cholesterol lowering effect of plant sterols is well established and it is also known that plant stanols inhibit the absorption of cholesterol. However, there is lack of dose-response studies directly measuring the cholesterol absorption efficiency during prolonged consumption of plant stanols. Therefore this study aims to measure the cholesterol absorption efficiency at different plant stanol consumption levels using a stable isotope tracer method.

Subjects will be randomized in their study groups that consume 20 g of margarine with different doses of plants stanols (0.8, 1.6 and 2.0g) based on cholesterol absorption efficiency at screening (high and low absorbers randomised separately). Cholesterol absorption test with cholesterol tracer will be conducted twice: at baseline and after 2-3 weeks margarine consumption period.

Cholesterol absorption efficiency will also be examined by indirect method i.e. by following the concentrations of serum cholesterol precursors and plant sterols in blood. In addition serum total, LDL and HDL cholesterol and triglycerides are followed.

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Treatment
Official Title:
The Effect of Three Different Stanol Ester Doses in Margarines on Cholesterol Absorption Efficiency
Study Start Date :
Mar 1, 2007
Actual Study Completion Date :
May 1, 2007

Outcome Measures

Primary Outcome Measures

  1. cholesterol absorption efficiency []

Secondary Outcome Measures

  1. changes in blood lipids []

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 68 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • healthy adults with mild to moderate hypercholesterolemia
Exclusion Criteria:
  • lipid lowering medication

  • pregnancy or lactation

  • severe diseases (inc. diabetes, unstable CVD, malignant diseases)

  • severe obesity

  • regular plant sterol consumption

Contacts and Locations

Locations

Site City State Country Postal Code
1 Oy Foodfiles Ltd Kuopio Finland 70210

Sponsors and Collaborators

  • Oy Foodfiles Ltd

Investigators

  • Principal Investigator: Sakari A Nieminen, MD, Oy Foodfiles Ltd

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00441857
Other Study ID Numbers:
  • DOSE
First Posted:
Mar 1, 2007
Last Update Posted:
Jul 6, 2007
Last Verified:
Jul 1, 2007
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 6, 2007